Review



aaas  (Linseis Messgerate)


Bioz Verified Symbol Linseis Messgerate is a verified supplier
Bioz Manufacturer Symbol Linseis Messgerate manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Linseis Messgerate aaas
    Mass loss (%) conducted <t>using</t> <t>HP3-DSC</t> at a rate of 10°C/min from 30 to 300 °C for <t>AAAS</t> silicate.
    Aaas, supplied by Linseis Messgerate, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sta/STA+HP+L85/pmc07377079-232-5-11
    Average 90 stars, based on 2 article reviews
    aaas - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "Application of a Novel and Sustainable Silicate Solution as an Alternative to Sodium Silicate for Clay Swelling Inhibition"

    Article Title: Application of a Novel and Sustainable Silicate Solution as an Alternative to Sodium Silicate for Clay Swelling Inhibition

    Journal: ACS Omega

    doi: 10.1021/acsomega.0c01777

    Mass loss (%) conducted using HP3-DSC at a rate of 10°C/min from 30 to 300 °C for AAAS silicate.
    Figure Legend Snippet: Mass loss (%) conducted using HP3-DSC at a rate of 10°C/min from 30 to 300 °C for AAAS silicate.

    Techniques Used:

    Related Articles

    other:

    Article Title: Application of a Novel and Sustainable Silicate Solution as an Alternative to Sodium Silicate for Clay Swelling Inhibition
    Article Snippet: The thermogravimetric analysis (TGA) of AAAS was conducted using HP3-DSC from Linseis.



    Similar Products

    99
    Linseis Messgerate nanomaterials
    Nanomaterials, supplied by Linseis Messgerate, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sta/STA+L81/pm42952270-226-5-12
    Average 99 stars, based on 1 article reviews
    nanomaterials - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Hitachi Ltd simultaneous thermal analyzer
    Simultaneous Thermal Analyzer, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sta/NEXTA+STA/pmc13766168-172-7-13
    Average 99 stars, based on 1 article reviews
    simultaneous thermal analyzer - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Hitachi Ltd simultaneous tga dsc analyzer
    Simultaneous Tga Dsc Analyzer, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sta/NEXTA+STA/pmc13762475-74-11-17
    Average 99 stars, based on 1 article reviews
    simultaneous tga dsc analyzer - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    85
    R&D Systems cd106 adhesion molecule vcam 1 apc biolegend sta
    Cd106 Adhesion Molecule Vcam 1 Apc Biolegend Sta, supplied by R&D Systems, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sta/Human+Integrin+alpha+5%2FCD49e+APC-conjugated+Antibody/10__1002_slash_osi2__70069-88-129-123
    Average 85 stars, based on 1 article reviews
    cd106 adhesion molecule vcam 1 apc biolegend sta - by Bioz Stars, 2026-11
    85/100 stars
      Buy from Supplier

    97
    Linseis Messgerate differential thermal analyses tga dta
    Differential Thermal Analyses Tga Dta, supplied by Linseis Messgerate, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sta/STA+L82/pmc13765836-105-9-15
    Average 97 stars, based on 1 article reviews
    differential thermal analyses tga dta - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    99
    Linseis Messgerate linseis l81 2400 high temperature
    Linseis L81 2400 High Temperature, supplied by Linseis Messgerate, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sta/STA+L81/10__1016_slash_j__commatsci__2026__115175-125-8-8
    Average 99 stars, based on 1 article reviews
    linseis l81 2400 high temperature - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    97
    Linseis Messgerate linseis sta pt 1000 instrument
    Linseis Sta Pt 1000 Instrument, supplied by Linseis Messgerate, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sta/STA+L82/pm42925829-84-42-42
    Average 97 stars, based on 1 article reviews
    linseis sta pt 1000 instrument - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    97
    Linseis Messgerate sta pt 1000 simultaneous thermal analyzer sta
    Sta Pt 1000 Simultaneous Thermal Analyzer Sta, supplied by Linseis Messgerate, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sta/STA+L82/pm42575355-103-7-6
    Average 97 stars, based on 1 article reviews
    sta pt 1000 simultaneous thermal analyzer sta - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    95
    Alomone Labs atx ii
    Effects of ANP and CNP ± Ocn on <t>ATX-II-induced</t> SR Ca 2+ leak in murine wild-type cardiomyocytes. ( A ) and ( D ) Representative confocal line scans of murine ventricular cardiomyocytes; ( B ) CaSpF was significantly increased by ATX-II compared with control (Con vs ATX-II: 0.7 ± 0.09 vs 1.4 ± 0.12 × 100 µm −1 s −1 ; n cells/hearts = 95/6 each, P < .001), CNP significantly lowered CaSpF compared with ATX-II (ATX-II vs ATX-II + CNP: 1.4 ± 0.12 vs 0.87 ± 0.07 × 100 µm −1 s −1 ; n cells/hearts = 95/6 vs 87/6, P < .001), ANP had no effect on CaSpF (ATX-II vs ATX-II + ANP: 1.4 ± 0.12 vs 1.4 ± 0.12 × 100 µm −1 s −1 , n cells/hearts = 95/6 each, P = .99). ( C ) CNP significantly elevated CaSp-amplitude compared with ATX-II (ATX-II vs ATX-II + CNP: ΔF/F 0 : 0.33 ± 0.11 vs 0.39 ± 0.011, n cells/hearts = 95/6 vs 87/6, P = .003), in contrast to ANP (ATX-II vs ATX-II + ANP: ΔF/F 0 : 0.33 ± 0.11 vs 0.37 ± 0.01, n cells/hearts = 95/6 vs 95/6, P = .098). ( E ) Ocn blunted CNP-induced effects on CaSpF (ATX-II + CNP vs ATX-II + CNP + Ocn: 0.75 ± 0.06 vs 1.22 ± 0.085 × 100 µm −1 s −1 , n cells/hearts = 78/5 vs 74/5, P < .001; ATX-II vs ATX-II + CNP + Ocn: 1.05 ± 0.07 vs 1.22 ± 0.085 × 100 µm −1 s −1 , n cells/hearts = 70/5 vs 74/5, P = .52). ( F ) CNP significantly elevated CaSp-amplitude compared with ATX-II (ATX-II vs ATX-II + CNP: ΔF/F 0 : 0.172 ± 0.006 vs 0.22 ± 0.011, n cells/hearts = 70/5 vs 78/5, P < .001). This effect was blunted after co-incubation with Ocn (ATX-II vs ATX-II + CNP + Ocn: ΔF/F 0 : 0.172 ± 0.006 vs 0.185 ± 0.006, n cells/hearts = 70/5 vs 74/5, P = .57). A one-way ANOVA with a Tukey post hoc test was used for the statistical analysis. * = P < .05; ** = P < .01; *** = P < .001; **** = P < .0001
    Atx Ii, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sta/ATX-II/pmc13674804-49-14-20
    Average 95 stars, based on 1 article reviews
    atx ii - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    Image Search Results


    Effects of ANP and CNP ± Ocn on ATX-II-induced SR Ca 2+ leak in murine wild-type cardiomyocytes. ( A ) and ( D ) Representative confocal line scans of murine ventricular cardiomyocytes; ( B ) CaSpF was significantly increased by ATX-II compared with control (Con vs ATX-II: 0.7 ± 0.09 vs 1.4 ± 0.12 × 100 µm −1 s −1 ; n cells/hearts = 95/6 each, P < .001), CNP significantly lowered CaSpF compared with ATX-II (ATX-II vs ATX-II + CNP: 1.4 ± 0.12 vs 0.87 ± 0.07 × 100 µm −1 s −1 ; n cells/hearts = 95/6 vs 87/6, P < .001), ANP had no effect on CaSpF (ATX-II vs ATX-II + ANP: 1.4 ± 0.12 vs 1.4 ± 0.12 × 100 µm −1 s −1 , n cells/hearts = 95/6 each, P = .99). ( C ) CNP significantly elevated CaSp-amplitude compared with ATX-II (ATX-II vs ATX-II + CNP: ΔF/F 0 : 0.33 ± 0.11 vs 0.39 ± 0.011, n cells/hearts = 95/6 vs 87/6, P = .003), in contrast to ANP (ATX-II vs ATX-II + ANP: ΔF/F 0 : 0.33 ± 0.11 vs 0.37 ± 0.01, n cells/hearts = 95/6 vs 95/6, P = .098). ( E ) Ocn blunted CNP-induced effects on CaSpF (ATX-II + CNP vs ATX-II + CNP + Ocn: 0.75 ± 0.06 vs 1.22 ± 0.085 × 100 µm −1 s −1 , n cells/hearts = 78/5 vs 74/5, P < .001; ATX-II vs ATX-II + CNP + Ocn: 1.05 ± 0.07 vs 1.22 ± 0.085 × 100 µm −1 s −1 , n cells/hearts = 70/5 vs 74/5, P = .52). ( F ) CNP significantly elevated CaSp-amplitude compared with ATX-II (ATX-II vs ATX-II + CNP: ΔF/F 0 : 0.172 ± 0.006 vs 0.22 ± 0.011, n cells/hearts = 70/5 vs 78/5, P < .001). This effect was blunted after co-incubation with Ocn (ATX-II vs ATX-II + CNP + Ocn: ΔF/F 0 : 0.172 ± 0.006 vs 0.185 ± 0.006, n cells/hearts = 70/5 vs 74/5, P = .57). A one-way ANOVA with a Tukey post hoc test was used for the statistical analysis. * = P < .05; ** = P < .01; *** = P < .001; **** = P < .0001

    Journal: ESC Heart Failure

    Article Title: Sacubitrilat exerts potent antiarrhythmic effects through activation of natriuretic peptide receptor-C

    doi: 10.1093/eschf/xvag253

    Figure Lengend Snippet: Effects of ANP and CNP ± Ocn on ATX-II-induced SR Ca 2+ leak in murine wild-type cardiomyocytes. ( A ) and ( D ) Representative confocal line scans of murine ventricular cardiomyocytes; ( B ) CaSpF was significantly increased by ATX-II compared with control (Con vs ATX-II: 0.7 ± 0.09 vs 1.4 ± 0.12 × 100 µm −1 s −1 ; n cells/hearts = 95/6 each, P < .001), CNP significantly lowered CaSpF compared with ATX-II (ATX-II vs ATX-II + CNP: 1.4 ± 0.12 vs 0.87 ± 0.07 × 100 µm −1 s −1 ; n cells/hearts = 95/6 vs 87/6, P < .001), ANP had no effect on CaSpF (ATX-II vs ATX-II + ANP: 1.4 ± 0.12 vs 1.4 ± 0.12 × 100 µm −1 s −1 , n cells/hearts = 95/6 each, P = .99). ( C ) CNP significantly elevated CaSp-amplitude compared with ATX-II (ATX-II vs ATX-II + CNP: ΔF/F 0 : 0.33 ± 0.11 vs 0.39 ± 0.011, n cells/hearts = 95/6 vs 87/6, P = .003), in contrast to ANP (ATX-II vs ATX-II + ANP: ΔF/F 0 : 0.33 ± 0.11 vs 0.37 ± 0.01, n cells/hearts = 95/6 vs 95/6, P = .098). ( E ) Ocn blunted CNP-induced effects on CaSpF (ATX-II + CNP vs ATX-II + CNP + Ocn: 0.75 ± 0.06 vs 1.22 ± 0.085 × 100 µm −1 s −1 , n cells/hearts = 78/5 vs 74/5, P < .001; ATX-II vs ATX-II + CNP + Ocn: 1.05 ± 0.07 vs 1.22 ± 0.085 × 100 µm −1 s −1 , n cells/hearts = 70/5 vs 74/5, P = .52). ( F ) CNP significantly elevated CaSp-amplitude compared with ATX-II (ATX-II vs ATX-II + CNP: ΔF/F 0 : 0.172 ± 0.006 vs 0.22 ± 0.011, n cells/hearts = 70/5 vs 78/5, P < .001). This effect was blunted after co-incubation with Ocn (ATX-II vs ATX-II + CNP + Ocn: ΔF/F 0 : 0.172 ± 0.006 vs 0.185 ± 0.006, n cells/hearts = 70/5 vs 74/5, P = .57). A one-way ANOVA with a Tukey post hoc test was used for the statistical analysis. * = P < .05; ** = P < .01; *** = P < .001; **** = P < .0001

    Article Snippet: The late sodium current (late I Na ) was increased by the addition of ATX-II (5 nmol/l or 0.5 nmol/l, Alomone Labs, Jerusalem, Israel) as described previously to induce an imbalance of Na + -/Ca 2+ -homeostasis mimicking conditions found in heart failure., For the initial proof-of-concept experiments comparing the effects of ANP and CNP, cardiomyocytes were challenged with 5 nmol/L ATX-II to establish a robust arrhythmogenic phenotype.

    Techniques: Confocal, Control, Incubation, Analysis

    Effects of Ocn under basal conditions and on ATX-induced diastolic SR Ca 2+ leak as well as cANP 4-23 on ATX-induced SR Ca 2+ leak in murine wild-type cardiomyocytes. ( A ) and ( C ) Representative confocal line scans of murine ventricular cardiomyocytes; ( B ) Ocn did not significantly change CaSpF under basal conditions (Con vs Ocn: 0.33 ± 0.04 vs 0.24 ± 0.04 × 100 µm −1 s −1 , n cells/hearts = 70/4 vs 69/4, P = .51) as well as under stimulation with ATX-II (ATX-II vs ATX-II + Ocn: 0.53 ± 0.06 vs 0.46 ± 0.05 × 100 µm −1 s −1 , n cells/hearts = 68/4 vs 67/4, P = .68). ( D ) cANP 4-23 significantly reduced CaSpF compared with ATX-II (0.69 ± 0.12 vs 0.23 ± 0.05 × 100 µm −1 s −1 , n cells/hearts = 43/3 each, P = .006). A one-way ANOVA with a Tukey post hoc test was used for the statistical analysis. ** = P < .01; *** = P < .001

    Journal: ESC Heart Failure

    Article Title: Sacubitrilat exerts potent antiarrhythmic effects through activation of natriuretic peptide receptor-C

    doi: 10.1093/eschf/xvag253

    Figure Lengend Snippet: Effects of Ocn under basal conditions and on ATX-induced diastolic SR Ca 2+ leak as well as cANP 4-23 on ATX-induced SR Ca 2+ leak in murine wild-type cardiomyocytes. ( A ) and ( C ) Representative confocal line scans of murine ventricular cardiomyocytes; ( B ) Ocn did not significantly change CaSpF under basal conditions (Con vs Ocn: 0.33 ± 0.04 vs 0.24 ± 0.04 × 100 µm −1 s −1 , n cells/hearts = 70/4 vs 69/4, P = .51) as well as under stimulation with ATX-II (ATX-II vs ATX-II + Ocn: 0.53 ± 0.06 vs 0.46 ± 0.05 × 100 µm −1 s −1 , n cells/hearts = 68/4 vs 67/4, P = .68). ( D ) cANP 4-23 significantly reduced CaSpF compared with ATX-II (0.69 ± 0.12 vs 0.23 ± 0.05 × 100 µm −1 s −1 , n cells/hearts = 43/3 each, P = .006). A one-way ANOVA with a Tukey post hoc test was used for the statistical analysis. ** = P < .01; *** = P < .001

    Article Snippet: The late sodium current (late I Na ) was increased by the addition of ATX-II (5 nmol/l or 0.5 nmol/l, Alomone Labs, Jerusalem, Israel) as described previously to induce an imbalance of Na + -/Ca 2+ -homeostasis mimicking conditions found in heart failure., For the initial proof-of-concept experiments comparing the effects of ANP and CNP, cardiomyocytes were challenged with 5 nmol/L ATX-II to establish a robust arrhythmogenic phenotype.

    Techniques: Confocal, Analysis, Confocal Microscopy

    Effects of Sac ± Ocn on ATX- induced SR Ca 2+ leak in murine ventricular cardiomyocytes. ( A ) Representative confocal line scans of murine ventricular cardiomyocytes; ( B ) Sac significantly reduced CaSpF compared with ATX-II (ATX-II vs ATX-II + Sac: 0.82 ± 0.08 vs 0.51 ± 0.07 × 100 µm −1 s −1 , n cells/hearts = 84/5 vs 87/5, P = .014). Upon Co-Incubation with Ocn the effect on CaSpF was blunted (ATX-II vs ATX-II + Sac + Ocn: 0.82 ± 0.08 vs 0.9 ± 0.09 × 100 µm −1 s −1 , n cells/hearts = 84/5 vs 86/5, P = .87; ATX-II + Sac vs ATX-II + Sac + Ocn: 0.51 ± 0.07 vs 0.9 ± 0.09 × 100 µm −1 s −1 , n cells/hearts = 87/5 vs 86/5, P = .001). ( C ) Sac increased CaSp-amplitude compared with ATX-II (ATX-II vs ATX-II + Sac: ΔF/F 0 : 0.175 ± 0.006 vs 0.21 ± 0.009, n cells/hearts = 84/5 vs 87/5, P = .001), but not upon co-incubation with Ocn (ATX-II vs ATX-II + Sac + Ocn: ΔF/F 0 : 0.175 ± 0.006 vs 0.2 ± 0.006, n cells/hearts = 84/5 vs 86/5, P = .69). A one-way ANOVA with a Tukey post hoc test was used for the statistical analysis. * = P < .05; ** = P < .01; *** = P < .001

    Journal: ESC Heart Failure

    Article Title: Sacubitrilat exerts potent antiarrhythmic effects through activation of natriuretic peptide receptor-C

    doi: 10.1093/eschf/xvag253

    Figure Lengend Snippet: Effects of Sac ± Ocn on ATX- induced SR Ca 2+ leak in murine ventricular cardiomyocytes. ( A ) Representative confocal line scans of murine ventricular cardiomyocytes; ( B ) Sac significantly reduced CaSpF compared with ATX-II (ATX-II vs ATX-II + Sac: 0.82 ± 0.08 vs 0.51 ± 0.07 × 100 µm −1 s −1 , n cells/hearts = 84/5 vs 87/5, P = .014). Upon Co-Incubation with Ocn the effect on CaSpF was blunted (ATX-II vs ATX-II + Sac + Ocn: 0.82 ± 0.08 vs 0.9 ± 0.09 × 100 µm −1 s −1 , n cells/hearts = 84/5 vs 86/5, P = .87; ATX-II + Sac vs ATX-II + Sac + Ocn: 0.51 ± 0.07 vs 0.9 ± 0.09 × 100 µm −1 s −1 , n cells/hearts = 87/5 vs 86/5, P = .001). ( C ) Sac increased CaSp-amplitude compared with ATX-II (ATX-II vs ATX-II + Sac: ΔF/F 0 : 0.175 ± 0.006 vs 0.21 ± 0.009, n cells/hearts = 84/5 vs 87/5, P = .001), but not upon co-incubation with Ocn (ATX-II vs ATX-II + Sac + Ocn: ΔF/F 0 : 0.175 ± 0.006 vs 0.2 ± 0.006, n cells/hearts = 84/5 vs 86/5, P = .69). A one-way ANOVA with a Tukey post hoc test was used for the statistical analysis. * = P < .05; ** = P < .01; *** = P < .001

    Article Snippet: The late sodium current (late I Na ) was increased by the addition of ATX-II (5 nmol/l or 0.5 nmol/l, Alomone Labs, Jerusalem, Israel) as described previously to induce an imbalance of Na + -/Ca 2+ -homeostasis mimicking conditions found in heart failure., For the initial proof-of-concept experiments comparing the effects of ANP and CNP, cardiomyocytes were challenged with 5 nmol/L ATX-II to establish a robust arrhythmogenic phenotype.

    Techniques: Confocal, Incubation, Analysis

    Effects of CNP and Sac ± Ocn on calcium transients and kinetics. ( A–D ) CNP as well as CNP ± Ocn did not significantly change calcium transient amplitude (ATX-II vs ATX-II + CNP: ΔF 405 /F 485 : 0.43 ± 0.03 vs 0.41 ± 0.02, n cells/hearts = 66/5 vs 76/5, P = .89; ATX-II vs ATX-II + CNP + Ocn: ΔF 405 /F 485 : 0.43 ± 0.03 vs 0.50 ± 0.02, n cells/hearts = 66/5 vs 73/5, P = .23) as well as diastolic calcium load compared with ATX-II (ATX-II vs ATX-II + CNP: F 405 /F 485 : 1.02 ± 0.015 vs 0.98 ± 0.015, n cells/hearts = 68/5 vs 76/5, P = .46.; ATX-II vs ATX-II + CNP + Ocn: F 405 /F 485 : 1.02 ± 0.015 vs 1.01 ± 0.018, n cells/hearts = 68/5 vs 73/5, P = .99). RT-50 was significantly reduced by CNP and CNP + Ocn compared with ATX-II (ATX-II vs ATX-II + CNP: 0.122 ± 0.003 vs 0.106 ± 0.003 s, n cells/hearts = 66/5 vs 76/5, P = .003; ATX-II vs ATX-II + CNP + Ocn: 0.122 ± 0.003 vs 0.101 ± 0.003 s, n cells/hearts = 66/5 vs 73/5, P < .001). ( E–H ) Sac did not influence calcium transient amplitude (ATX-II vs ATX-II + Sac: 0.39 ± 0.03 vs 0.41 ± 0.02, n cells/hearts = 56/4 vs 52/4, P = .97), diastolic calcium load (ATX-II vs ATX-II + Sac: 1.04 ± 0.03 vs 1–13 ± 0.03, n cells/hearts = 56/4 vs 54/4, P = .54) and RT-50 (ATX-II vs ATX-II + Sac: 0.108 ± 0.003 vs 0.099 ± 0.002, n cells/hearts = 56/4 vs 52/4, P = .11) compared with ATX-II. Co-incubation of Sac and osteocrin lead to significantly higher calcium transient amplitudes (ATX-II vs ATX-II + Sac + Ocn: 0.39 ± 0.03 vs 0.7 ± 0.12, n cells/hearts = 56/4 vs 60/4, P = .01) and higher diastolic calcium load (ATX-II vs ATX-II + Sac + Ocn: 1.04 ± 0.03 vs 1.25 ± 0.07, n cells/hearts = 56/4 vs 62/4, P = .004) and to a significantly lower RT-50 (ATX-II vs ATX-II + Sac + Ocn: 0.108 ± 0.003 vs 0.096 ± 0.002 s, n cells/hearts = 56/4 vs 60/4, P = .01) compared with ATX-II. A one-way ANOVA with a Tukey post hoc test was used for the statistical analysis. * = P < .05; ** = P < .01; **** = P < .0001

    Journal: ESC Heart Failure

    Article Title: Sacubitrilat exerts potent antiarrhythmic effects through activation of natriuretic peptide receptor-C

    doi: 10.1093/eschf/xvag253

    Figure Lengend Snippet: Effects of CNP and Sac ± Ocn on calcium transients and kinetics. ( A–D ) CNP as well as CNP ± Ocn did not significantly change calcium transient amplitude (ATX-II vs ATX-II + CNP: ΔF 405 /F 485 : 0.43 ± 0.03 vs 0.41 ± 0.02, n cells/hearts = 66/5 vs 76/5, P = .89; ATX-II vs ATX-II + CNP + Ocn: ΔF 405 /F 485 : 0.43 ± 0.03 vs 0.50 ± 0.02, n cells/hearts = 66/5 vs 73/5, P = .23) as well as diastolic calcium load compared with ATX-II (ATX-II vs ATX-II + CNP: F 405 /F 485 : 1.02 ± 0.015 vs 0.98 ± 0.015, n cells/hearts = 68/5 vs 76/5, P = .46.; ATX-II vs ATX-II + CNP + Ocn: F 405 /F 485 : 1.02 ± 0.015 vs 1.01 ± 0.018, n cells/hearts = 68/5 vs 73/5, P = .99). RT-50 was significantly reduced by CNP and CNP + Ocn compared with ATX-II (ATX-II vs ATX-II + CNP: 0.122 ± 0.003 vs 0.106 ± 0.003 s, n cells/hearts = 66/5 vs 76/5, P = .003; ATX-II vs ATX-II + CNP + Ocn: 0.122 ± 0.003 vs 0.101 ± 0.003 s, n cells/hearts = 66/5 vs 73/5, P < .001). ( E–H ) Sac did not influence calcium transient amplitude (ATX-II vs ATX-II + Sac: 0.39 ± 0.03 vs 0.41 ± 0.02, n cells/hearts = 56/4 vs 52/4, P = .97), diastolic calcium load (ATX-II vs ATX-II + Sac: 1.04 ± 0.03 vs 1–13 ± 0.03, n cells/hearts = 56/4 vs 54/4, P = .54) and RT-50 (ATX-II vs ATX-II + Sac: 0.108 ± 0.003 vs 0.099 ± 0.002, n cells/hearts = 56/4 vs 52/4, P = .11) compared with ATX-II. Co-incubation of Sac and osteocrin lead to significantly higher calcium transient amplitudes (ATX-II vs ATX-II + Sac + Ocn: 0.39 ± 0.03 vs 0.7 ± 0.12, n cells/hearts = 56/4 vs 60/4, P = .01) and higher diastolic calcium load (ATX-II vs ATX-II + Sac + Ocn: 1.04 ± 0.03 vs 1.25 ± 0.07, n cells/hearts = 56/4 vs 62/4, P = .004) and to a significantly lower RT-50 (ATX-II vs ATX-II + Sac + Ocn: 0.108 ± 0.003 vs 0.096 ± 0.002 s, n cells/hearts = 56/4 vs 60/4, P = .01) compared with ATX-II. A one-way ANOVA with a Tukey post hoc test was used for the statistical analysis. * = P < .05; ** = P < .01; **** = P < .0001

    Article Snippet: The late sodium current (late I Na ) was increased by the addition of ATX-II (5 nmol/l or 0.5 nmol/l, Alomone Labs, Jerusalem, Israel) as described previously to induce an imbalance of Na + -/Ca 2+ -homeostasis mimicking conditions found in heart failure., For the initial proof-of-concept experiments comparing the effects of ANP and CNP, cardiomyocytes were challenged with 5 nmol/L ATX-II to establish a robust arrhythmogenic phenotype.

    Techniques: Incubation, Analysis

    Effects of CNP and Sac ± Ocn on caffeine induced calcium transients. ( A–D ) CNP alone and in combination with Ocn did not significantly influence caffeine-induced Ca 2+ -transient amplitude (ATX-II vs ATX-II + CNP: ΔF 405 /F 485 : 0.21 ± 0.017 vs 0.25 ± 0.036, n cells/hearts = 17/5 vs 11/4, P = .08; ATX-II vs ATX-II + CNP + Ocn: ΔF 405 /F 485 : 0.21 ± 0.02 vs 0.21 ± 0.02, n cells/hearts = 17/5 vs 17/5, P = .43), RT-50 (ATX-II vs ATX-II + CNP: 0.6 ± 0.005 s vs 0.82 ± 0.1 s, n cells/hearts = 17/5 vs 11/4, P = .41; ATX-II vs ATX-II + CNP + Ocn: 0.6 ± 0.05 s vs 0.79 ± 0.08 s, n cells/hearts = 17/5 vs 17/5, P = .45) or the rate constant reflecting SERCA activity (ATX-II vs ATX-II + CNP: 4.6 ± 0.3 s −1 vs 6.9 ± 0.75 s −1 , n cells/hearts = 17/5 vs 11/5, P = .08; ATX-II vs ATX-II + CNP + Ocn: 4.6 ± 0.3 s −1 vs 5.9 ± 0.05 s −1 , n cells/hearts = 17/5 vs 17/5, P = .43). ( E–H ) Sac as well as Sac + Ocn did not significantly change caffeine-induced Ca 2+ -transient amplitude (ATX-II vs ATX-II + Sac: ΔF 405 /F 485 : 0.18 ± 0.04 vs 0.14 ± 0.012, n cells/hearts = 15/5 vs 18/5, P = .67;, ATX-II vs ATX-II + Sac + Ocn: ΔF 405 /F 485 : 0.18 ± 0.04 vs 0.24 ± 0.03, n cells/hearts = 15/5 vs 16/5, P = .36), RT-50 (ATX-II vs ATX-II + Sac: 0.7 ± 0.07 s vs 0.9 ± 0.1 s, n cells/hearts = 12/5 vs 17/5, P = .59; ATX-II vs ATX-II + Sac + Ocn: 0.7 ± 0.07 s vs 0.93 ± 0.17 s, n cells/hearts = 12/5 vs 11/5, P = .55) and the rate constant compared with ATX-II (ATX-II vs ATX-II + Sac: 4.9 ± 0.46 s −1 vs 4.9 ± 0.51 s −1 , n cells/hearts = 15/5 vs 17/5, P = .95; ATX-II vs ATX-II + Sac + Ocn: 4.9 ± 0.46 s −1 vs 5.6 ± 0.44 s −1 , n cells/hearts = 15/5 vs 16/5, P = .98). A one-way ANOVA with a Tukey post hoc test was used for the statistical analysis. * = P < .05; *** = P < .001

    Journal: ESC Heart Failure

    Article Title: Sacubitrilat exerts potent antiarrhythmic effects through activation of natriuretic peptide receptor-C

    doi: 10.1093/eschf/xvag253

    Figure Lengend Snippet: Effects of CNP and Sac ± Ocn on caffeine induced calcium transients. ( A–D ) CNP alone and in combination with Ocn did not significantly influence caffeine-induced Ca 2+ -transient amplitude (ATX-II vs ATX-II + CNP: ΔF 405 /F 485 : 0.21 ± 0.017 vs 0.25 ± 0.036, n cells/hearts = 17/5 vs 11/4, P = .08; ATX-II vs ATX-II + CNP + Ocn: ΔF 405 /F 485 : 0.21 ± 0.02 vs 0.21 ± 0.02, n cells/hearts = 17/5 vs 17/5, P = .43), RT-50 (ATX-II vs ATX-II + CNP: 0.6 ± 0.005 s vs 0.82 ± 0.1 s, n cells/hearts = 17/5 vs 11/4, P = .41; ATX-II vs ATX-II + CNP + Ocn: 0.6 ± 0.05 s vs 0.79 ± 0.08 s, n cells/hearts = 17/5 vs 17/5, P = .45) or the rate constant reflecting SERCA activity (ATX-II vs ATX-II + CNP: 4.6 ± 0.3 s −1 vs 6.9 ± 0.75 s −1 , n cells/hearts = 17/5 vs 11/5, P = .08; ATX-II vs ATX-II + CNP + Ocn: 4.6 ± 0.3 s −1 vs 5.9 ± 0.05 s −1 , n cells/hearts = 17/5 vs 17/5, P = .43). ( E–H ) Sac as well as Sac + Ocn did not significantly change caffeine-induced Ca 2+ -transient amplitude (ATX-II vs ATX-II + Sac: ΔF 405 /F 485 : 0.18 ± 0.04 vs 0.14 ± 0.012, n cells/hearts = 15/5 vs 18/5, P = .67;, ATX-II vs ATX-II + Sac + Ocn: ΔF 405 /F 485 : 0.18 ± 0.04 vs 0.24 ± 0.03, n cells/hearts = 15/5 vs 16/5, P = .36), RT-50 (ATX-II vs ATX-II + Sac: 0.7 ± 0.07 s vs 0.9 ± 0.1 s, n cells/hearts = 12/5 vs 17/5, P = .59; ATX-II vs ATX-II + Sac + Ocn: 0.7 ± 0.07 s vs 0.93 ± 0.17 s, n cells/hearts = 12/5 vs 11/5, P = .55) and the rate constant compared with ATX-II (ATX-II vs ATX-II + Sac: 4.9 ± 0.46 s −1 vs 4.9 ± 0.51 s −1 , n cells/hearts = 15/5 vs 17/5, P = .95; ATX-II vs ATX-II + Sac + Ocn: 4.9 ± 0.46 s −1 vs 5.6 ± 0.44 s −1 , n cells/hearts = 15/5 vs 16/5, P = .98). A one-way ANOVA with a Tukey post hoc test was used for the statistical analysis. * = P < .05; *** = P < .001

    Article Snippet: The late sodium current (late I Na ) was increased by the addition of ATX-II (5 nmol/l or 0.5 nmol/l, Alomone Labs, Jerusalem, Israel) as described previously to induce an imbalance of Na + -/Ca 2+ -homeostasis mimicking conditions found in heart failure., For the initial proof-of-concept experiments comparing the effects of ANP and CNP, cardiomyocytes were challenged with 5 nmol/L ATX-II to establish a robust arrhythmogenic phenotype.

    Techniques: Activity Assay, Analysis